Androgenetic alopecia
Conditions
Interventions
Polycystic Ovary Syndrome with Androgenetic Alopecia Group :None
Polycystic Ovary Syndrome without Androgenetic Alopecia Group :None
Sponsors
Beijing Friendship Hospital, Capital Medical University
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Patients diagnosed with PCOS according to the Rotterdam criteria at Beijing Friendship Hospital, Capital Medical University, i.e., those presenting any two of the following three features: (1) irregular menstrual cycles (cycle length >=45 days or =8 or serum total testosterone >=50 ng/dL); (3) polycystic ovarian morphology (ovarian volume >10 mL or>=12 follicles with a diameter of 2–9 mm); 2. Female patients aged 18 years or above who have not undergone menopause. 3. Availability of laboratory test results in the medical record system (including but not limited to endocrine six-item tests, which may cover anti-Müllerian hormone, biochemical C6, dehydroepiandrosterone sulfate, thyroid series, etc.), as well as reports from transabdominal/transvaginal ultrasound examinations, among others.
Exclusion criteria
Exclusion criteria: 1. Use of any relevant medications within 6 months prior to laboratory tests, such as oral contraceptives, insulin sensitizers, anti-androgen drugs, or Chinese herbal medicines; 2. Use of any relevant medications within 6 months prior to offline follow-up, such as oral contraceptives, insulin sensitizers, anti-androgen drugs, or Chinese herbal medicines; 3. Patients with other endocrine or organic disorders, such as hyperprolactinemia, thyroid dysfunction, Cushing's syndrome, congenital adrenal hyperplasia, adrenal or ovarian tumors, or impaired liver/kidney function; 4. Patients with severe traumatic injuries, infections, or severe systemic diseases; 5. Patients with oligomenorrhea due to other causes; 6. Pregnant or lactating women; 7. Individuals deemed ineligible by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ludwig scale for andrgenetic alopecia; | — |
Secondary
| Measure | Time frame |
|---|---|
| Basic demographic information;Laboratory parameters;Medical history and treatment history; | — |
Countries
China
Contacts
Public ContactFenglin Zhuo
Beijing Friendship Hospital, Capital Medical University
Outcome results
None listed